MAGT1 and glioma: Further, MAGT1 silencing resulted in suppressed viability of the cells and MAGT1 overexpression led to the opposite; meanwhile, the glioma cell viability-promoting property of MAGT1 overexpression was reversed by its combination with U0126-induced ERK inhibition (Figure 4).